Form D Explorer

Form C-AR — 20/20 Biolabs, Inc.

0001139685-25-000003 · filed 2025-05-20

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

Name
20/20 Biolabs, Inc.
CIK
1139685
Entity
Corporation
Jurisdiction
DE
Address
15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877
Phone
—

Most recent fiscal year financials

Total assets
$3,584,408
Cash
—
Short-term debt
$1,355,078
Long-term debt
$723,848
Revenues
$1,752,343
COGS
$1,373,432
Taxes paid
—
Net income
$-5,126,667

Same issuer's Form D filings

View original on SEC EDGAR.